• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nuvation Bio Inc (NY: NUVB )

    3.020 +0.030 (+1.00%)
    Official Closing Price Updated: 7:00 PM EDT, Jun 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,358,312
    Open 3.160
    Bid (Size) 2.950 (5)
    Ask (Size) 3.120 (13)
    Prev. Close 2.990
    Today's Range 2.985 - 3.260
    52wk Range 0.9500 - 4.160
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting
    From Nuvation Bio Inc.
    Via Business Wire
    Nuvation Bio to Present at the Jefferies Global Healthcare Conference
    From Nuvation Bio Inc.
    Via Business Wire

    Performance

    YTD
    +92.36%
    +92.36%
    1 Month
    -11.44%
    -11.44%
    3 Month
    +33.63%
    +33.63%
    6 Month
    +115.71%
    +115.71%
    1 Year
    +71.59%
    +71.59%

    More News

    Read More
    NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024
    Via InvestorPlace
    Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update
    From Nuvation Bio Inc.
    Via Business Wire
    Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    From Nuvation Bio Inc.
    Via Business Wire
    Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Nuvation Bio Completes Acquisition of AnHeart Therapeutics
    From Nuvation Bio Inc.
    Via Business Wire
    ProfoundBio Discovers The Joys Of Having A Wealthy Owner
    Via Benzinga
    Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal
    Via Talk Markets
    Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
    From Nuvation Bio Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
    From Nuvation Bio Inc.
    Via Business Wire
    Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors
    From Nuvation Bio Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.